Out-of-pocket expenses for diabetes treatment have gone down for many U.S. patients over the past decade, according to a new study. But nearly a quarter of people with diabetes still face high expenses. In particular, (out-of-pocket) expenses declined in the people with public insurance and in people with low income …
Read More »Diabetes In Control
Obesity Blamed for Rise in Diabetes
An ‘alarming’ rise in obesity has contributed to a dramatic increase in the prevalence of diabetes in the U.S, according to a new study. Researchers examined the prevalence of diabetes, prediabetes, and glycemic control in 43,439 adults in the NHANES study from 1988 to 1994 and 1999 to 2010. The …
Read More »In Two Decades, Diabetes Doubled
The authors of a new study found that the rise in diabetes from 5.5% to 9.3% of the U.S. population over the last 20 years paralleled the growing rate of obesity in America. Better screening tools such as the HbA1c diagnostic test have also helped physicians identify more diabetes cases, …
Read More »Renal Failure Associated with Depression in Adults with Diabetes
Diabetic patients who are depressed may be at an increased risk for developing end-stage renal disease….
Read More »Fatty Liver Disease Tied to Diabetes, Atherosclerosis
Non-alcoholic fatty liver disease (NAFLD) is an independent predictor of both type 2 diabetes and carotid atherosclerosis, according to two studies….
Read More »Diabetic Women Less Likely to Undergo Mammograms
Women with diabetes were 14% less likely than those without the disease to undergo breast cancer screening….
Read More »AHA Questions Salt Intake Study
The American Heart Association questions the findings of a new analysis suggesting that most people around the world are consuming just the right amount of sodium….
Read More »Vitamin D Not Linked with Heart Risk in Men
Circulating levels of vitamin D had no apparent influence on overall risk for cardiovascular disease in older men….
Read More »FDA Approves Albiglutide, a Once-Weekly GLP-1 Injectable Diabetes Drug
The Food and Drug Administration (FDA) has approved albiglutide (Tanzeum, GlaxoSmithKline), a once-weekly injectable glucagonlike peptide 1 (GLP-1) receptor agonist to treat type 2 diabetes…. “Tanzeum is a new treatment option for the millions of Americans living with type 2 diabetes,” Curtis Rosebraugh, MD, MPH, director of the Office of …
Read More »Are Chromium Supplements Effective in Lowering Blood Sugars?
A new study by a University of Miami (UM) researcher analyzed nearly three decades of data on the effect of chromium supplementation on blood sugars….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.